Terminated PHASE2 INTERVENTIONAL 2-arm NCT01048567

Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly

Use of Lactobacillus Acidophilus/Rhamnosus Complex for the Prevention of Antibiotic-associated Diarrhea in Elderly Hospitalized Patients

Sponsor: Canadian Society of Hospital Pharmacists

Conditions Clostridium Difficile Diarrhea

Interventions Lactobacillus acidophilus/rhamnosus Placebo

Updated 5 times since 2017 Last updated: Dec 17, 2013 Started: Sep 30, 2011 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient resources to meet enrollment target

Other Clostridium Difficile trials with similar outcome

Browse all Clostridium Difficile trials

A PHASE2 clinical study on Clostridium Difficile and Diarrhea, this trial is terminated or withdrawn. The trial is conducted by Canadian Society of Hospital Pharmacists and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Society of Hospital Pharmacists
Jamieson Laboratories Ltd, Canada
Vancouver Island Health Authority

Data source: Vancouver Island Health Authority

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Victoria, Canada